Tirzepatide 30mg

Tirzepatide 30mg — Research Overview

Tirzepatide 30mg is a dual-receptor peptide compound investigated in metabolic research for its interaction with GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) pathways. This dual-action profile makes tirzepatide a valuable research tool for studying insulin signalling, glucose regulation and energy balance. This compound is supplied by ReGen-X exclusively for scientific and laboratory research.

Mechanism of Action (Research Context)
In controlled research environments, tirzepatide interacts with the following pathways:

• GLP-1 receptors — involved in glucose regulation and appetite signalling
• GIP receptors — associated with insulin secretion and fat metabolism

The dual-agonist combination allows researchers to study synergistic metabolic pathway modulation in endocrine and metabolic systems.

Research Summary
Tirzepatide has been examined in research environments for its potential role in:

• Glycaemic control pathways
• Insulin sensitivity and signalling
• Energy balance and nutrient utilisation
• Lipid and fat metabolism research

Browse our full range of Metabolic & GLP-1 research compounds.

Product Specifications

• Compound: Tirzepatide 30mg
• Quantity: 30mg
• Form: Lyophilised research peptide
• Included: 10ml bacteriostatic water (for laboratory reconstitution only)
• Storage: Refrigerated per laboratory standards

Important Research Use Notice
This product is sold strictly for laboratory and scientific research use only. It is not a medicine, not a supplement, and not approved for human or veterinary use. No medical, therapeutic, or health claims are made or implied.